Mini‐review: Regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross‐priming and direct priming?
暂无分享,去创建一个
[1] Susan M. Kaech,et al. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol. , 2002 .
[2] Michel C. Nussenzweig,et al. Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance , 2002, The Journal of experimental medicine.
[3] K. Legge,et al. Accelerated migration of respiratory dendritic cells to the regional lymph nodes is limited to the early phase of pulmonary infection. , 2003, Immunity.
[4] A. Rickinson,et al. The Importance of Exogenous Antigen in Priming the Human CD8+ T Cell Response: Lessons from the EBV Nuclear Antigen EBNA11 , 2000, The Journal of Immunology.
[5] Susan M. Kaech,et al. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells , 2001, Nature Immunology.
[6] R. Steinman,et al. The CD8+ Dendritic Cell Subset Selectively Endocytoses Dying Cells in Culture and In Vivo , 2002, The Journal of experimental medicine.
[7] G. Randolph. Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. , 2001, Seminars in immunology.
[8] R. Offringa,et al. Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. , 1998, Journal of immunology.
[9] L. Frappier,et al. Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. , 1997, Immunity.
[10] S. Jolles,et al. Systemic treatment with anti‐CD40 antibody stimulates Langerhans cell migration from the skin , 2002, Clinical and experimental immunology.
[11] S. Akira,et al. A Toll-like receptor recognizes bacterial DNA , 2000, Nature.
[12] C. Melief,et al. Antigen-Antibody Immune Complexes Empower Dendritic Cells to Efficiently Prime Specific CD8+ CTL Responses In Vivo1 , 2002, The Journal of Immunology.
[13] Kayo Nakamura,et al. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. , 2002, Immunity.
[14] Yong‐jun Liu,et al. Mouse and human dendritic cell subtypes , 2002, Nature Reviews Immunology.
[15] K. Rock,et al. Bone Marrow–Derived Antigen-Presenting Cells Are Required for the Generation of Cytotoxic T Lymphocyte Responses to Viruses and Use Transporter Associated with Antigen Presentation (Tap)-Dependent and -Independent Pathways of Antigen Presentation , 2000, The Journal of experimental medicine.
[16] R. Andino,et al. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen , 1999, Nature.
[17] R. Birge,et al. alphavbeta5 integrin recruits the CrkII-Dock180-rac1 complex for phagocytosis of apoptotic cells. , 2000, Nature cell biology.
[18] Scott N. Mueller,et al. The CD8α+ Dendritic Cell Is Responsible for Inducing Peripheral Self-Tolerance to Tissue-associated Antigens , 2002, The Journal of experimental medicine.
[19] Nina Bhardwaj,et al. Consequences of cell death: exposure to necrotic tumor cells , 2000 .
[20] P. Srivastava. Roles of heat-shock proteins in innate and adaptive immunity , 2002, Nature Reviews Immunology.
[21] W. Oyen,et al. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. , 2003, Cancer research.
[22] F. Sallusto,et al. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. , 2001, Current opinion in immunology.
[23] Urs Christen,et al. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes , 2003, Nature.
[24] J. Davoust,et al. Accumulation of Immature Langerhans Cells in Human Lymph Nodes Draining Chronically Inflamed Skin , 2002, The Journal of experimental medicine.
[25] J. Miller,et al. CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[26] T. Blankenstein,et al. Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells. , 1997, Journal of immunology.
[27] C Caux,et al. Immunobiology of dendritic cells. , 2000, Annual review of immunology.
[28] P. Romero,et al. OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway , 2000, Nature Immunology.
[29] M. Bevan,et al. Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo , 2000, The Journal of experimental medicine.
[30] P. Ricciardi-Castagnoli,et al. Immature Dendritic Cells Acquire Cd8+Cytotoxic T Lymphocyte Priming Capacity upon Activation by T Helper Cell–Independent or–Dependent Stimuli , 2000, The Journal of experimental medicine.
[31] Matthew L. Albert,et al. αvβ5 integrin recruits the CrkII–Dock180–Rac1 complex for phagocytosis of apoptotic cells , 2000, Nature Cell Biology.
[32] Stephen P. Schoenberger,et al. Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation , 2001, Nature Immunology.
[33] L. Adorini,et al. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. , 2002, Human immunology.
[34] T. Schumacher,et al. CD27 is required for generation and long-term maintenance of T cell immunity , 2000, Nature Immunology.
[35] M. Bevan,et al. Antigen presentation to CD8+ T cells: cross-priming in infectious diseases. , 2001, Current opinion in immunology.
[36] P. Godowski,et al. Cutting Edge: Bacterial Flagellin Activates Basolaterally Expressed TLR5 to Induce Epithelial Proinflammatory Gene Expression1 , 2001, The Journal of Immunology.
[37] S. H. van der Burg,et al. Strategies for immunotherapy of cancer. , 2000, Advances in immunology.
[38] C. Kurts,et al. Class I–restricted Cross-Presentation of Exogenous Self-Antigens Leads to Deletion of Autoreactive CD8+ T Cells , 1997, The Journal of experimental medicine.
[39] Michel C. Nussenzweig,et al. Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo , 2001, The Journal of experimental medicine.
[40] Loise M. Francisco,et al. Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes , 1998, The Journal of experimental medicine.
[41] U. Yrlid,et al. Salmonella-Induced Apoptosis of Infected Macrophages Results in Presentation of a Bacteria-Encoded Antigen after Uptake by Bystander Dendritic Cells , 2000, The Journal of experimental medicine.
[42] R. Zinkernagel. On cross‐priming of MHC class I‐specific CTL: rule or exception? , 2002, European journal of immunology.
[43] S. Akira,et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.
[44] P. Ricciardi-Castagnoli,et al. Interactions of bacterial pathogens with dendritic cells during invasion of mucosal surfaces. , 2003, Current opinion in microbiology.
[45] W. Heath,et al. Cross-presentation, dendritic cells, tolerance and immunity. , 2001, Annual review of immunology.
[46] Stephen P. Schoenberger,et al. T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions , 1998, Nature.
[47] R. Offringa,et al. CD40 stimulation leads to effective therapy of CD40− tumors through induction of strong systemic cytotoxic T lymphocyte immunity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[48] R. Steinman,et al. Immune Tolerance After Delivery of Dying Cells to Dendritic Cells In Situ , 2002, The Journal of experimental medicine.
[49] Steffen Jung,et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. , 2002, Immunity.
[50] J. Ravetch,et al. Inducing Tumor Immunity through the Selective Engagement of Activating Fcγ Receptors on Dendritic Cells , 2002, The Journal of experimental medicine.
[51] C. Melief,et al. Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors , 1998, The Journal of experimental medicine.
[52] S. Godefroy,et al. Outer membrane protein A renders dendritic cells and macrophages responsive to CCL21 and triggers dendritic cell migration to secondary lymphoid organs , 2003, European journal of immunology.
[53] Ferry Ossendorp,et al. CD4 T Cells and Their Role in Antitumor Immune Responses , 1999, The Journal of experimental medicine.
[54] G. Randolph,et al. Is Maturation Required for Langerhans Cell Migration? , 2002, The Journal of experimental medicine.
[55] D. Schwartz,et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans , 2000, Nature Genetics.
[56] E. Pamer,et al. Feedback regulation of pathogen-specific T cell priming. , 2003, Immunity.
[57] Laurence Zitvogel,et al. Antigen presentation and T cell stimulation by dendritic cells. , 2002, Annual review of immunology.
[58] M. Croft,et al. 4–1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity , 2002, European journal of immunology.
[59] M. Nishimura,et al. Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells. , 2002, Immunity.
[60] J. Yewdell. Not such a dismal science: the economics of protein synthesis, folding, degradation and antigen processing. , 2001, Trends in cell biology.
[61] Michel C. Nussenzweig,et al. Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[62] Rolf M. Zinkernagel,et al. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction , 2001, Nature.
[63] R. Andino,et al. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen , 1999, Nature.
[64] J. Yewdell,et al. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. , 1999, Annual review of immunology.
[65] M. Kalos,et al. CD8+ T Cell Tolerance to a Tumor-associated Antigen Is Maintained at the Level of Expansion Rather than Effector Function , 2002, The Journal of experimental medicine.
[66] M. Albert,et al. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs , 1998, Nature.
[67] M. Stanley,et al. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential , 2002, Clinical and experimental dermatology.
[68] M. Croft,et al. Signaling through OX40 (CD134) breaks peripheral T-cell tolerance , 2001, Nature Medicine.
[69] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[70] M. Neutra,et al. Cholera Toxin Induces Migration of Dendritic Cells from the Subepithelial Dome Region to T- and B-Cell Areas of Peyer's Patches , 2003, Infection and Immunity.
[71] B. Rocha,et al. A Role for CD40 Expression on CD8+ T Cells in the Generation of CD8+ T Cell Memory , 2002, Science.
[72] P. Ricciardi-Castagnoli,et al. Fcγ Receptor–mediated Induction of Dendritic Cell Maturation and Major Histocompatibility Complex Class I–restricted Antigen Presentation after Immune Complex Internalization , 1999, The Journal of experimental medicine.
[73] Javier Hernández,et al. Phenotypic and Functional Analysis of Cd8+ T Cells Undergoing Peripheral Deletion in Response to Cross-Presentation of Self-Antigen , 2001, The Journal of experimental medicine.
[74] Sebastian Amigorena,et al. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells , 1999, Nature Cell Biology.
[75] R. Offringa,et al. In Vivo Triggering Through 4-1BB Enables Th-Independent Priming of CTL in the Presence of an Intact CD28 Costimulatory Pathway1 , 2002, The Journal of Immunology.
[76] G. Hartmann,et al. Combined dendritic cell‐ and CpG oligonucleotide‐based immune therapy cures large murine tumors that resist chemotherapy , 2002, European journal of immunology.
[77] Richard A. Flavell,et al. Help for cytotoxic-T-cell responses is mediated by CD40 signalling , 1998, Nature.
[78] Polly Matzinger,et al. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell , 1998, Nature.
[79] G. Freeman,et al. Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. , 1999, Immunity.
[80] S. H. van der Burg,et al. Established Human Papillomavirus Type 16-Expressing Tumors Are Effectively Eradicated Following Vaccination with Long Peptides1 , 2002, The Journal of Immunology.
[81] N. Bhardwaj,et al. Interactions between dead cells and dendritic cells in the induction of antiviral CTL responses. , 2002, Current opinion in immunology.